Overcoming metabolic stress is a critical step for solid tumour growth 1, 2 . However, the underlying mechanisms of cell death and survival under metabolic stress are not well understood. A key signalling pathway involved in metabolic adaptation is the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway 2, 3 . Energy stress conditions that decrease intracellular ATP levels below a certain level promote AMPK activation by LKB1. Previous studies showed that LKB1-deficient or AMPK-deficient cells are resistant to oncogenic transformation and tumorigenesis [4] [5] [6] , possibly because of the function of AMPK in metabolic adaptation. However, the mechanisms by which AMPK promotes metabolic adaptation in tumour cells are not fully understood. Here we show that AMPK activation, during energy stress, prolongs cell survival by redox regulation. Under these conditions, NADPH generation by the pentose phosphate pathway is impaired, but AMPK induces alternative routes to maintain NADPH and inhibit cell death. The inhibition of the acetyl-CoA carboxylases ACC1 and ACC2 by AMPK maintains NADPH levels by decreasing NADPH consumption in fatty-acid synthesis and increasing NADPH generation by means of fatty-acid oxidation. Knockdown of either ACC1 or ACC2 compensates for AMPK activation and facilitates anchorage-independent growth and solid tumour formation in vivo, whereas the activation of ACC1 or ACC2 attenuates these processes. Thus AMPK, in addition to its function in ATP homeostasis, has a key function in NADPH maintenance, which is critical for cancer cell survival under energy stress conditions, such as glucose limitations, anchorageindependent growth and solid tumour formation in vivo.
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The lack of LKB1 or AMPK activation rendered cancer cells more sensitive to cell death induced by glucose deprivation 5, [7] [8] [9] (Supplementary Fig. 1 ). However, the mechanism by which the failure to activate AMPK accelerates cancer cell death during energy stress remains to be explained. Our results demonstrate that the effect of AMPK does not involve p53 or mTORC1, which were implicated in the LKB1-AMPKmediated regulation of cell survival during glucose deprivation 8, 10 . In both control A549 cells (A549-Vect) and dominant-negative p53 (p53DN)-expressing A549 cells (A549-p53DN), LKB1 reconstitution restored AMPK activation, as measured by ACC phosphorylation, and inhibited glucose-starvation-induced cell death to a similar extent (Fig. 1a, b ). mTORC1 inhibition with rapamycin also did not affect the sensitivity of A549 cells to glucose deprivation (Fig. 1b) .
Replacement of glucose with the non-metabolizable glucose analogues 2-deoxyglucose (2DG) or 5-thioglucose (5TG) revealed that only 2DG protected LKB1-deficient cancer cells (A549 and HeLa) from glucose-starvation-induced cell death (Fig. 1b and Supplementary Fig. 2b ). Unlike 5TG, 2DG strongly induced the activation of AMPK, even in LKB1-deficient cells (Fig. 1a and Supplementary Fig. 2a ). This activation occurred by means of a poorly understood mechanism that is dependent on hexokinase ( Supplementary Fig. 3 ). The results suggest that, by activating AMPK, 2DG inhibits cell death during glucose deprivation. However, LKB1 reconstitution in A549 cells induced higher AMPK activation than 2DG (Fig. 1a ), yet 2DG Vector LKB1 Vector LKB1 protected the cells slightly better than LKB1 (Fig. 1b) , implying that 2DG could protect cells by both AMPK-dependent and AMPKindependent mechanisms.
Glucose limitations could induce oxidative stress by decreasing NADPH generation in the pentose phosphate pathway (PPP) (Fig. 1c) . NADPH is required for the regeneration of reduced glutathione (GSH), which is used by glutathione peroxidase (GPX) to eliminate H 2 O 2 (Fig. 1c) . We therefore speculated as follows: first, that the failure to activate AMPK by glucose deprivation accelerates cell death through oxidative stress mediated by decreased PPP flux and NADPH/GSH generation; second, that AMPK activation under these conditions is required to inhibit cell death by decreasing oxidative stress; and third, that 2DG protects the cells by both AMPK activation and partial utilization in the PPP 11 ( Fig. 1c) . We first established that decreased PPP flux and increased oxidative stress are the cause of the cell death. Glucose-6-phosphate dehydrogenase (G6PD) knockdown accelerated cell death in low glucose (Fig. 1d) and even in the absence of glucose ( Supplementary Fig. 4a, b) . Glucose deprivation rapidly depleted NADPH/GSH and elevated the H 2 O 2 level in control cells, which were further affected by G6PD knockdown ( Supplementary Fig. 4c-e) . Finally, the antioxidants N-acetylcysteine (NAC) and catalase inhibited cell death in LKB1-deficient or AMPKdeficient cells ( (Fig. 1f, g ), explaining increased cell death (Fig. 1e) , during glucose deprivation ( Supplementary Fig. 8 ). Similarly, AMPKaknockout (AMPKa-KO) murine embryonic fibroblasts (MEFs) failed to maintain their NADP 1 /NADPH ratio and low H 2 O 2 level after glucose starvation (Fig. 1i) . Finally, as we had speculated, 2DG maintained NADPH, GSH and H 2 O 2 levels and protected from cell death largely by means of AMPK activation and to a smaller extent by partial utilization in the PPP ( Supplementary Fig. 4 ). This could explain why 2DG protects from cell death slightly better than LKB1 despite higher activation of AMPK by LKB1 (Fig. 1b) . Thus, the combination of decreased NADPH generation by the PPP and impaired AMPK activation during glucose deprivation in LKB1-deficient or AMPK-deficient cells accelerates NADPH depletion and H 2 O 2 elevation, eventually causing cell death.
Next we investigated the mechanism by which AMPK maintains the NADPH level in the absence of glucose. The intracellular NADPH level is determined by the difference between its production and its consumption. NADPH is generated from the PPP and mitochondrial metabolism, and is consumed mainly during H 2 O 2 detoxification by GPX and peroxiredoxin (PRX) and fatty-acid synthesis (FAS) (Fig. 2a) . Under limited glucose supply, the major NADPH source is mitochondrial metabolism, which is supported by fatty-acid oxidation (FAO). Metabolites provided by FAO to the tricarboxylic acid cycle generate malate and citrate, the substrates of NADPH-producing malic enzyme and isocitrate dehydrogenase, respectively. AMPK regulates fatty-acid metabolism through the phosphorylation and inhibition of ACC1 and ACC2, which in turn inhibit FAS and activates FAO, respectively 12 . Both ACC1 and ACC2 generate malonyl-CoA, the precursor of FAS and a potent inhibitor of carnitine palmitoyltransferase 1 (CPT1), the ratelimiting enzyme in FAO 13 ( Fig. 2a) . We therefore reasoned that AMPK might regulate NADPH homeostasis by inhibiting ACC1 and ACC2.
We first determined whether targeting ACC1 or ACC2 inhibits cell death, the accumulation of H 2 O 2 and the depletion of NADPH observed during glucose deprivation. Targeting either ACC1 or ACC2 in A549 cells by short interfering RNAs (siRNAs) demonstrated that only ACC2 knockdown significantly inhibited cell death and H 2 O 2 accumulation, without decreasing O 2 2 ( Supplementary Fig. 9 ). We therefore generated stable cell lines expressing ACC2-specific short hairpin RNA (shRNA) (Supplementary Fig. 10a ). ACC2 knockdown in A549 cells maintained the NADP 1 /NADPH ratio (Fig. 2b) and the GSSG/GSH ratio (Fig. 2c) , inhibited the accumulation of H 2 O 2 ( Fig. 2d ) and prevented cell death (Fig. 2e) . Similar results were obtained in HeLa, MCF7-LKB1sh and H1703-LKB1sh cells ( Supplementary  Fig. 10b-d ). Targeting either ACC1 or ACC2 in AMPKa-KO MEFs significantly decreased the H 2 O 2 level during glucose starvation ( Supplementary Fig. 11 ). The inability of ACC1 knockdown in A549 cells to decrease the H 2 O 2 level during glucose starvation was probably because FAS inhibition in these cells occurs to a similar extent regardless of LKB1 expression or ACC1 knockdown ( Supplementary  Fig. 12 ). In contrast, A549-LKB1 and A549-ACC2sh cells showed a RESEARCH LETTER marked increase in FAO, explaining why ACC2 knockdown was able to decrease H 2 O 2 levels but ACC1 knockdown was not ( Supplementary  Fig. 12 ). Consistently, overexpression of the constitutively active ACC2(S212A) mutant significantly inhibited FAO and sensitized MCF7 cells to glucose-deprivation-mediated cell death, and partly blocked protection by 2DG in HeLa cells (Supplementary Fig. 13 ). Furthermore, short-term exposure to the FAS inhibitor C75, which also activates CPT1, mimicking the effects of AMPK on fatty-acid metabolism, lowered the NADP 1 /NADPH ratio and protected A549 and HeLa cells during glucose deprivation (Fig. 2b and Supplementary  Fig. 14a, b) . However, because C75 inhibits FAS downstream of ACC1, long-term treatment with C75 leads to the cytotoxic accumulation of malonyl-CoA 14 . Indeed, etomoxir, a CPT1 inhibitor, abrogated the short-term effect of C75 without affecting the effect of NAC (Supplementary Fig. 14c ). These results indicate that the short-term protective effect of C75 was largely due to the activation of CPT1 and the acceleration of FAO. Furthermore, treatment with the ACC inhibitor TOFA protected from cell death, whereas the malate supplement alone could not (Supplementary Fig. 15a) . However, the combination of TOFA and malate further protected from cell death ( Supplementary  Fig. 15a ). These results suggest that malate alone is not sufficient to induce NADPH accumulation, because NADPH could still be consumed by FAS. Thus, when FAS is inhibited by TOFA, malate can promote sufficient NADPH accumulation to inhibit cell death during glucose deprivation. Finally, the protective effect of ACC2 knockdown was abrogated by buthionine sulfoximine, which depletes GSH, but not by nicotinamide (NAM), which inhibits Sirt1, excluding a possible involvement of the NAD 1 -Sirt1 pathway 15 ( Supplementary Fig. 15b ). Like glucose starvation, matrix detachment elicits energy stress followed by elevated H 2 O 2 levels and cell death 16 . Indeed, matrix detachment inhibited glucose uptake in A549 cells ( Supplementary  Fig. 16 ), and markedly activated AMPK in A549-LKB1 cells (Fig. 3a) . AMPK was also activated in A549 cells but to a much smaller extent than in A549-LKB1 cells (Fig. 3a) , which is dependent on calmodulindependent protein kinase kinase (CaMKK; Fig. 3b ). We therefore tested whether AMPK activation is required for redox regulation during matrix detachment and anchorage-independent growth, which is a hallmark of cancer cells. Matrix detachment significantly increased the H 2 O 2 level in A549-Vect cells in comparison with A549-LKB1 cells, regardless of p53 status (Fig. 3c) . CaMKK inhibition in A549 cells further elevated the H 2 O 2 level during matrix detachment (Fig. 3d) , supporting a key function for AMPK in redox regulation during this process. The results were confirmed in MCF7 cells with LKB1 knockdown or AMPKa1 knockdown (Supplementary Fig. 17 ). The impaired AMPK activation and the higher H 2 O 2 level in matrix-detached A549 cells were correlated to the extent of NADPH depletion (Fig. 3e) . The high NADP 1 /NADPH ratio in A549 cells was further increased after matrix detachment, whereas the low NADP 1 /NADPH ratio was maintained in A549-LKB1 cells (Fig. 3e) .
We next investigated whether ACCs mediate the effect of AMPK during matrix detachment. Knockdown of ACC1 by siRNA, but not that of ACC2, blocked the increase in the H 2 O 2 level by matrix detachment ( Supplementary Fig. 18 ). We therefore used A549 cells expressing ACC1-specific shRNA (Supplementary Fig. 19 ) and confirmed that ACC1 knockdown markedly decreased the NADP 1 /NADPH ratio and H 2 O 2 level (Fig. 3f, g ). Finally, the ACC inhibitor TOFA, but not the mTORC1 inhibitor rapamycin, decreased the H 2 O 2 level (Supplementary Fig. 20) . LKB1 expression had a more pronounced effect on FAS inhibition than on FAO increase (Supplementary Fig. 21a ). This effect was recapitulated by ACC1 knockdown ( Supplementary  Fig. 21b ), explaining why ACC1 knockdown could decrease the H 2 O 2 level.
We then assessed whether redox regulation by ACCs has a function in anchorage-independent growth. Consistent with previous observations 16 , we found that treatment of A549 cells and AMPKa-KO-Ras
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MEFs with NAC substantially increased the number of colonies ( Fig. 4a and Supplementary Fig. 22 ). Inhibition of CaMKK markedly inhibited anchorage-independent growth, which was rescued by NAC treatment (Fig. 4a and Supplementary Fig. 22a ). Targeting either ACC1 or ACC2 substantially increased the number of colonies on soft agar and recapitulated the effect of NAC (Fig. 4b, c and Supplementary  Fig. 23 ). However, the average colony size was increased only by ACC1 knockdown (Fig. 4b, c) , which may reflect the predominant function of ACC1 in controlling the H 2 O 2 level after matrix detachment.
To assess further the function of ACCs in anchorage-independent growth, we overexpressed the ACC1(S79A) and ACC2(S212A) mutants in two LKB1-proficient cell lines, MCF7 and H1703. Both mutants increased FAS and the H 2 O 2 level after matrix detachment ( Fig. 4d and Supplementary Fig. 24a ), and potently inhibited anchorage-independent growth, which was partly rescued by NAC (Fig. 4e and Supplementary Fig. 24b, c) . These results indicate that the inhibition of either ACC1 or ACC2 by AMPK is required for anchorageindependent growth by means of redox regulation. In contrast, ACC1 knockdown or ACC2 knockdown in LKB1-reconstituted HeLa cells 
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inhibited anchorage-independent growth (Supplementary Fig. 25a) . Thus, when AMPK is activated, further inhibition of ACC1 or ACC2 could not enhance tumorigenesis, instead attenuating it.
During the formation of a solid tumour, cells undergo metabolic stress including glucose deprivation and matrix detachment. Indeed, it has been shown that AMPKa-KO-Ras V12 MEFs are severely impaired in their ability to form tumours in vivo 6 and that AMPK is activated during the early stages of solid tumour formation 17 . Thus, to determine whether ACCs have a function in solid tumour formation in vivo, we performed xenograft assays using A549 and AMPKa-KO-Ras
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MEFs expressing shRNAs targeting ACC1 or ACC2. Knockdown of ACC1 or ACC2 significantly enhanced tumour formation in vivo (Fig. 4f, g) ; the latter had a more pronounced effect on tumour growth than the former. However, neither ACC1 knockdown or ACC2 knockdown in A549-LKB1 cells had much effect on tumour growth ( Supplementary Fig. 25b ), further suggesting that physiological inhibition of ACC by AMPK, but not enhanced inhibition, is required to promote solid tumour growth. To assess these results further, we performed orthotopic transplantation using MCF7 cells. The knockdown of either LKB1 or AMPKa1 in MCF7 cells significantly inhibited orthotopic tumour growth (Supplementary Fig. 26a ). To test the function of ACC1 and ACC2 phosphorylation by AMPK in tumour growth, MCF7 cells expressing either ACC1(S79A) or ACC2(S212A) were subjected to orthotopic transplantation. Consistent with the in vitro results (Fig. 4e) , ACC2(S212A) expression significantly inhibited solid tumour growth; ACC1(S79A) expression also inhibited tumour growth, although to a smaller extent, under two different experimental conditions ( Fig. 4h and Supplementary Fig. 26b ). Taken together, these results demonstrate that NADPH maintenance through AMPK-ACC1/ ACC2 is critical for solid tumour growth in vivo (Fig. 4i) . It was previously reported that ACC2 expression is significantly downregulated in papillary thyroid cancer 18 , supporting a tumour-suppressor function for ACC2 in certain contexts. Moreover, consistent with our results, it was shown that overexpression of CPT1 promotes solid tumour growth through the activation of FAO 19 . Our results are not inconsistent with results showing that inhibition of FAS by the knockdown of fatty acid synthase (FASN) or ATP-citrate lyase (ACLY) inhibits tumorigenesis 20, 21 because, unlike the inhibition of ACC, the inhibition of FASN or ACLY exerts additional cytotoxic effects. These cytotoxic effects seem to be through the accumulation of malonyl-CoA but not through the direct inhibition of FAS itself 14, 22, 23 , and through the inhibition of acetylation without decreasing lipid contents 24, 25 . Our results seem paradoxical because of the tumour suppressor activity of LKB1-AMPK, partly through mTORC1 inhibition 3 . We propose that during glucose limitations or matrix depletion, AMPK activation, at physiological levels, is required for NADPH homeostasis, which surpasses the requirement for mTORC1 activity. Combating energy stress conditions by AMPK is particularly important in the early stages of solid tumour formation when cells migrate to the lumen, or during metastasis when cells migrate from the primary tumour to a different location. However, AMPK activation is probably occurring in a temporal manner, because FAO could also increase the ATP level ( Supplementary Fig. 27 ), which would eventually inhibit AMPK. Our results therefore do not necessarily contradict the possibility that prolonged and robust AMPK activation inhibits cancer cell proliferation. In fact, they suggest that a combination of metabolic inhibitors, such as 2DG or metformin, and ACC activators could synergistically decrease cancer cell survival by concurrently inhibiting mTORC1 and the pro-survival activity of AMPK. This combination could be more effective in LKB1-null cancer cells.
Our findings could explain why AMPK-deficient cells are resistant to oncogenic transformation 4, 6 . At the organismal level our results may explain why patients with Peutz-Jeghers syndrome, who have V12 cells (g) expressing LacZ-shRNA, ACC1-shRNA, or ACC2-shRNA were injected subcutaneously into nude mice. h, MCF7 cells expressing vector, ACC1-S79A or ACC2-S212A were mixed with Matrigel (10%) and injected orthotopically into the mammary fat pads of nude mice. Tumour growth was monitored and measured weekly. Results are shown as means and s.e.m. for four mice in each group. Asterisk, P , 0.05; two asterisks, P , 0.01; three asterisks, P , 0.005; hash, P , 0.001 versus LacZsh (b, c), vector (d) or 2NAC in each group (e), and versus LacZ-shRNA (f, g) or vector (h) at each time point. i, Summary: under energy stress when PPP is impaired, AMPK activation attenuates cell death by maintaining NADPH level through FAOinduced NADPH production and by inhibiting NADPH consumption in FAS. AI growth, anchorage-independent growth. j, Proposed model: in addition to its function in ATP homeostasis, the LKB1/CaMKK-AMPK/ACC1/2 axis has a key function in NADPH homeostasis to decrease H 2 O 2 level and to promote cancer cell survival and metabolic adaptation.
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an inherited deficiency of LKB1, and most mouse models of LKB1 deficiency develop only benign tumours 4 . Although somatic mutations in LKB1 are rare in most cancers, the mutations are prevalent in certain cancers, such as non-small cell lung carcinoma and cervical carcinoma 3 . In mouse models, deficiency in LKB1 also promotes Ras-induced lung tumorigenesis 26 . One possible explanation is that certain microenvironmental factors may enable AMPK activation in the absence of LKB1 through other upstream activators, such as CaMKK, as shown in Fig. 3b . In addition, LKB1 deficiency may affect other multiple downstream effectors of LKB1 (ref. 26 ) that could circumvent the requirement for the LKB1-AMPK pathway during the early stages of solid tumour formation.
AMPK is known to maintain intracellular ATP level under conditions of energy stress. Consistently, we found that AMPK maintains ATP level in addition to NADPH level under these conditions (Supplementary Fig. 27a ). However, NAC, which protected from cell death, did not restore ATP level during glucose starvation ( Supplementary  Fig. 27b ), indicating that NADPH maintenance rather than ATP maintenance is the predominant mechanism by which AMPK promotes cell survival during metabolic stress (Fig. 4j) .
Our study shows that under conditions of energy stress, when NADPH generation from the PPP is impaired, AMPK activation is required for the maintenance of NADPH level by inhibiting ACC1 and/or ACC2 (Fig. 4i, j) . This function of AMPK is critical for cancer cell survival during metabolic stress, which can occur in the solid tumour microenvironment.
METHODS SUMMARY
For glucose deprivation the cells were incubated in glucose-free DMEM medium containing 10% dialysed FBS; for matrix detachment the cells were plated on poly-HEMA-coated plates for the indicated periods. Cell death was measured by staining with 49,6-diamidino-2-phenylindole (DAPI) or with a trypan blue exclusion assay. The intracellular levels of H 2 O 2 and O 2 2 were measured by flow cytometry with 29,79-dichlorofluorescein diacetate (DCF-DA) and dihydroethidium (DHE), respectively. The NADPH and GSH assays were performed using enzymatic cycling methods, and ATP level was measured using the ATPlite assay (Perkin Elmer). Fatty-acid synthesis was measured by detecting The soft agar assays were performed in the presence or absence of 2 mM NAC for 3-4 weeks, and the colony number and size were analysed using ImageJ software. For the xenograft assays, A549 (2 3 10 6 cells) or MEFs (5 3 10 6 cells) were injected subcutaneously into the flanks, and MCF7 (5 3 10 6 cells) were orthotopically injected into the mammary fat pads in athymic nude mice. Tumour size was measured every week. Statistical analyses were performed with unpaired two-tailed Student's t-tests, and unless otherwise indicated all data are expressed as means and s.e.m. for three independent experiments.
